newsfilter
← Latest News
ACCESS Newswire·

NLS Pharmaceutics Announces Receipt of Additional Staff Delisting Determination from Nasdaq

ZÜRICH, SWITZERLAND / ACCESSWIRE / May 24, 2024 / NLS Pharmaceutics Ltd. , a Swiss clinical-stage biopharmaceutical company focused on the